Elysium Health
Revolutionary health products, based on advances in science and technology, to help people live healthier for longer.
| USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 55 % | - | (34 %) | 107 % | 4 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Elysium Health operates in the life sciences sector, focusing on developing scientifically-backed health products aimed at improving cellular aging, DNA health, and brain function. The company serves health-conscious consumers who are interested in proactive health management and longevity. Elysium Health's business model revolves around direct-to-consumer sales of its flagship products, including Basis, Matter, and Index. Basis is a supplement clinically proven to increase NAD levels, which are essential for cellular health. Matter is designed to slow age-related brain atrophy with a specific B vitamin complex. Index is an at-home test that uses epigenetics technology to determine biological age. The company generates revenue through online sales and subscription models, ensuring a steady stream of income. Elysium Health differentiates itself through its commitment to scientific research and partnerships with leading academic institutions.
Keywords: cellular aging, DNA health, brain function, NAD levels, epigenetics, biological age, supplements, direct-to-consumer, scientific research, longevity.